In particular, common genes resulted to be associated with the Cancer drug response by drug efflux and PXR/RXR activation pathways, as well as to Breast cancer regulation by Stathmin 1, 14-3-3-mediated signalling and NRF2-mediated oxidative stress response pathways (Fig. 2B). Here, NR1I2 is linked to breast cancer.